180 related articles for article (PubMed ID: 29347844)
1. Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives.
Ganou CA; Eleftheriou PT; Theodosis-Nobelos P; Fesatidou M; Geronikaki AA; Lialiaris T; Rekka EA
SAR QSAR Environ Res; 2018 Feb; 29(2):133-149. PubMed ID: 29347844
[TBL] [Abstract][Full Text] [Related]
2. Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis: An application on the discovery of novel effective PTP1B inhibitors.
Eleftheriou P; Petrou A; Geronikaki A; Liaras K; Dirnali S; Anna M
SAR QSAR Environ Res; 2015; 26(7-9):557-76. PubMed ID: 26294069
[TBL] [Abstract][Full Text] [Related]
3. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.
Kostrzewa T; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Kuban-Jankowska A
Drug Des Devel Ther; 2018; 12():4139-4147. PubMed ID: 30584278
[TBL] [Abstract][Full Text] [Related]
5. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
SarathKumar B; Lakshmi BS
J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid.
Baskaran SK; Goswami N; Selvaraj S; Muthusamy VS; Lakshmi BS
J Chem Inf Model; 2012 Aug; 52(8):2004-12. PubMed ID: 22747429
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
Mahapatra MK; Kumar R; Kumar M
Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
[TBL] [Abstract][Full Text] [Related]
8. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
9. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
[TBL] [Abstract][Full Text] [Related]
10. Discovery of core-structurally novel PTP1B inhibitors with specific selectivity containing oxindole-fused spirotetrahydrofurochroman by one-pot reaction.
Dong S; Lei Y; Jia S; Gao L; Li J; Zhu T; Liu S; Hu W
Bioorg Med Chem Lett; 2017 Feb; 27(4):1105-1108. PubMed ID: 28111140
[TBL] [Abstract][Full Text] [Related]
11. PTP1B inhibitors from Selaginella tamariscina (Beauv.) Spring and their kinetic properties and molecular docking simulation.
Le DD; Nguyen DH; Zhao BT; Seong SH; Choi JS; Kim SK; Kim JA; Min BS; Woo MH
Bioorg Chem; 2017 Jun; 72():273-281. PubMed ID: 28499188
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the inhibitory activity of natural tanshinones from Salvia miltiorrhiza roots on protein tyrosine phosphatase 1B.
Kim DH; Paudel P; Yu T; Ngo TM; Kim JA; Jung HA; Yokozawa T; Choi JS
Chem Biol Interact; 2017 Dec; 278():65-73. PubMed ID: 29031618
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 2,4,6-trihydroxychalcone derivatives as novel protein tyrosine phosphatase 1B inhibitors.
Sun LP; Gao LX; Ma WP; Nan FJ; Li J; Piao HR
Chem Biol Drug Des; 2012 Oct; 80(4):584-90. PubMed ID: 22805439
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents.
Seong SH; Roy A; Jung HA; Jung HJ; Choi JS
J Ethnopharmacol; 2016 Dec; 194():706-716. PubMed ID: 27769948
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and insulin-sensitising effects of novel PTP1B inhibitors.
Tang YB; Lu D; Chen Z; Hu C; Yang Y; Tian JY; Ye F; Wu L; Zhang ZY; Xiao Z
Bioorg Med Chem Lett; 2013 Apr; 23(8):2313-8. PubMed ID: 23499238
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
[TBL] [Abstract][Full Text] [Related]
17. Discovery and evaluation of the hybrid of bromophenol and saccharide as potent and selective protein tyrosine phosphatase 1B inhibitors.
Zhang R; Yu R; Xu Q; Li X; Luo J; Jiang B; Wang L; Guo S; Wu N; Shi D
Eur J Med Chem; 2017 Jul; 134():24-33. PubMed ID: 28395151
[TBL] [Abstract][Full Text] [Related]
18. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking.
Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S
Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
Liu P; Du Y; Song L; Shen J; Li Q
Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
[TBL] [Abstract][Full Text] [Related]
20. Covalent Allosteric Inactivation of Protein Tyrosine Phosphatase 1B (PTP1B) by an Inhibitor-Electrophile Conjugate.
Punthasee P; Laciak AR; Cummings AH; Ruddraraju KV; Lewis SM; Hillebrand R; Singh H; Tanner JJ; Gates KS
Biochemistry; 2017 Apr; 56(14):2051-2060. PubMed ID: 28345882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
